Publication
Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer
dc.contributor.author | Costa, Bruna Pasqualotto | |
dc.contributor.author | Schein, Vanessa | |
dc.contributor.author | Zhao, R. | |
dc.contributor.author | Santos, Andressa Schneiders | |
dc.contributor.author | Kliemann, Lucia Maria | |
dc.contributor.author | Nunes, Fernanda Bordignon | |
dc.contributor.author | Cardoso, João CR | |
dc.contributor.author | C. Félix, Rute | |
dc.contributor.author | Canario, Adelino | |
dc.contributor.author | Brum, Ilma Simoni | |
dc.contributor.author | Branchini, Gisele | |
dc.date.accessioned | 2020-09-01T13:18:01Z | |
dc.date.available | 2021-02-01T01:30:16Z | |
dc.date.issued | 2020-02 | |
dc.description.abstract | Prostate cancer (PCa) is one of the most prevalent male tumours. Stanniocalcin-1 (STC1) is a glycoprotein and, although the role of STC1 in human cancer is poorly understood, it is suggested to be involved in the development and progression of different neoplasms. This study investigated the protein expression profile of STC1 in PCa and benign prostatic hyperplasia (BPH) samples and STC1 signalling during cell proliferation and cell death in vitro using cell lines. We found higher levels of STC1 in PCa when compared to BPH tissue and that STC1 inhibited forskolin stimulation of cAMP in PC-3 cells. A monoclonal antibody against STC1 was effective in reducing cell proliferation, in promoting cell cycle arrest, and in increasing apoptosis in the same cells. Since STC1 acts as a regulator of prostatic tissue signalling, we suggest that this protein is a novel candidate biomarker for prostate tumour clinical progression and a potential therapeutic target. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.doi | 10.1016/j.mce.2019.110659 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.1/14664 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Elsevier | pt_PT |
dc.subject | Prostatic neoplasm | pt_PT |
dc.subject | Prostate cancer | pt_PT |
dc.subject | Stanniocalcin-1 | pt_PT |
dc.subject | Tumour development | pt_PT |
dc.subject | Gleason score | pt_PT |
dc.title | Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.startPage | 110659 | pt_PT |
oaire.citation.title | Molecular and Cellular Endocrinology | pt_PT |
oaire.citation.volume | 502 | pt_PT |
person.familyName | Cardoso | |
person.familyName | Félix | |
person.familyName | Canario | |
person.givenName | João | |
person.givenName | Rute | |
person.givenName | Adelino | |
person.identifier | 14332 | |
person.identifier | 143624 | |
person.identifier.ciencia-id | 8B16-F203-2AFC | |
person.identifier.ciencia-id | FB1A-1325-8E25 | |
person.identifier.ciencia-id | 1F1E-D3B3-F804 | |
person.identifier.orcid | 0000-0001-7890-0170 | |
person.identifier.orcid | 0000-0002-4144-3452 | |
person.identifier.orcid | 0000-0002-6244-6468 | |
person.identifier.rid | M-4151-2013 | |
person.identifier.rid | M-6164-2013 | |
person.identifier.rid | C-7942-2009 | |
person.identifier.scopus-author-id | 7201822956 | |
person.identifier.scopus-author-id | 56006773000 | |
person.identifier.scopus-author-id | 56568523700 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 1b670c84-15e3-4776-8871-50f9eb0eed0d | |
relation.isAuthorOfPublication | 9b5e820d-e41f-4c28-8832-823658d29ae9 | |
relation.isAuthorOfPublication | 5f6e51ee-9113-469e-8b9e-f30f2d452521 | |
relation.isAuthorOfPublication.latestForDiscovery | 5f6e51ee-9113-469e-8b9e-f30f2d452521 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 2020 Joao Cardoso - Costa et al 2019_reviewed.pdf
- Size:
- 4.41 MB
- Format:
- Adobe Portable Document Format